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SAINT LOUIS UNIVERSITY SCHOOL OF LAW

EXAMINING SOCIODEMOGRAPHIC DATA REPORTING
REQUIREMENTS IN STATE DISEASE SURVEILLANCE SYSTEMS †
SAMANTHA BENT WEBER,* AMANDA MORELAND,**
RACHEL HULKOWER*** & TARA RAMANATHAN HOLIDAY****
ABSTRACT
Law plays an important role in the collection of data related to disease and
injury in a population. A robust system of laws sets out requirements for the
collection, analysis, and dissemination of disease reporting data from local,
state, territorial, and federal public health institutions. Occurrence of disease,
including outbreaks of novel infectious agents like coronaviruses, influenza
viruses, and others that have arisen in recent years, often require
epidemiologists and others to understand not only the etiology and specific
context of diseases and conditions, but also the trajectory of their spread among
and across communities. Capturing sociodemographic data is critical to
identifying the disproportionate impacts of diseases and conditions on diverse
populations and determining an appropriate public health response. This Article
discusses a legal epidemiological scan of state disease reporting laws that
require the capture and reporting of sociodemographic information. Analyzing
these state laws can serve as a potential starting point to assist in understanding
why gaps in data exist and can help address these challenges in anticipation of
future disease outbreaks or spread.
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I. BACKGROUND ON DISEASE REPORTING AND SURVEILLANCE
Since the inception of disease surveillance in the United States, the legal
foundation for tracking and monitoring the occurrence of disease and injury
within a population has been established through a combination of laws and
policies at various governmental levels. The Centers for Disease Control and
Prevention (CDC) houses the country’s most expansive disease surveillance
systems, including the National Notifiable Diseases Surveillance System
(NNDSS). The NNDSS receives case-level data from fifty-seven public health
jurisdictions, including states, localities, and territories, for the approximately
120 diseases and conditions that comprise the National Notifiable Conditions. 1
This disease surveillance system relies upon the jurisdictions’ voluntary
submission of data on infectious and noninfectious diseases and conditions that
have been deemed notifiable. 2 Jurisdictions remove information that would
identify the individual before submitting these data to CDC for use by the
disease-specific programs, which support state, local, and territorial public
health departments. 3 This surveillance system plays a critical role in monitoring,
preventing, and controlling the incidence of disease and injury across the
country.
Foundational to the NNDSS are the state, local, and territorial laws and
policies that require healthcare providers, healthcare facilities, laboratories, and
others to submit information on reportable diseases and conditions to the state,
local, or territorial public health department. 4 Each state, locality, and territory
has the legal authority to enact laws that determine which conditions are

1. 2020 National Notifiable Conditions (Historical), CTRS. FOR DISEASE CONTROL &
PREVENTION, https://ndc.services.cdc.gov/ (choose “2020” from “Year” dropdown menu under
“Notifiable Condition Lists”; then click “Get Notifiable List by Year” button) (last visited May 25,
2021). The fifty-seven jurisdictions include the fifty states, Washington D.C., New York City,
American Samoa, Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and U.S.
Virgin Islands. See Deborah Adams, et al., Summary of Notifiable Infectious Diseases and
Conditions – United States, 2013, 62 MORBIDITY & MORTALITY WKLY. REP. 1, 7 (Oct. 23, 2015).
2. National Notifiable Diseases Surveillance System Overview, CTRS. FOR DISEASE
CONTROL & PREVENTION, https://www.cdc.gov/nndss/docs/NNDSS-Overview-Fact-Sheet508.pdf (last updated Apr. 19, 2021). See also How We Conduct Case Surveillance, CTRS. FOR
DISEASE CONTROL & PREVENTION, https://www.cdc.gov/nndss/about/conduct.html (last updated
Apr. 16, 2021) [hereinafter CDC Case Surveillance] (“Case notification, in which state and local
health departments send deidentified data about confirmed cases of certain diseases and conditions
that are tracked nationally to CDC. Case notification is voluntary.”)
3. See National Notifiable Diseases Surveillance System Fact Sheet, CTRS. FOR DISEASE
CONTROL & PREVENTION 2 (2018), https://wwwn.cdc.gov/nndss/document/NNDSS-Fact-Sheet508.pdf.
4. In this article, “reportable diseases” will be used to refer to the list of identified diseases
and conditions that are required by state law to be reported to the state or local health departments,
while “notifiable diseases” refers to the list of diseases and conditions that jurisdictions voluntarily
report to CDC’s NNDSS for disease surveillance.
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reportable within its own jurisdiction, in addition to who must report and the
methods for reporting. 5 As such, the list of mandatory reportable diseases and
the manner in which they are reported vary by jurisdiction. 6 Many, though not
all, reportable diseases are also on the NNDSS list of Nationally Notifiable
Conditions. 7 The collection and dissemination of disease reporting data from
each jurisdiction is essential to the compilation of case notification information
that comprises NNDSS and other national surveillance systems.
II. THE IMPORTANCE OF SOCIODEMOGRAPHIC DATA IN DISEASE
SURVEILLANCE
Disease surveillance information is critical to designing and implementing
strategies to protect the public’s health. 8 Public health surveillance through
NNDSS and other systems allows epidemiologists to detect, track, and respond
to indicators of disease. 9 For example, some outbreaks involve new or
reemerging infectious diseases, which may make them more difficult to predict
or control. 10 Measuring and monitoring trends and changes to diseases,
including their incidence and the effectiveness of disease control measures,
requires the availability of information beyond just the disease name and clinical
data. 11
The collection of sociodemographic data is essential to disease control
efforts. Demographic data, or characteristics of individuals within a population,
such as age, race, sex, pregnancy status, employment status, or occupation, can
help to identify traits among those who are most affected by a disease, as well

5. CDC Case Surveillance, supra note 2.
6. Richard N. Danila et al., Legal Authority for Infectious Disease Reporting in the United
States: Case Study of the 2009 H1N1 Influenza Pandemic, 105 AM. J. PUB. HEALTH 13, 13 (2015).
7. CDC Case Surveillance, supra note 2 (stating that hospitals, providers, and laboratories
are required to report cases of certain diseases to health departments according to state disease
reporting laws, but local and state health departments can voluntarily send deidentified case
information to the CDC).
8. Perry F. Smith et al., “Blueprint Version 2.0”: Updating Public Health Surveillance for
the 21st Century, 19 J. PUB. HEALTH MGMT. & PRAC. 231, 237 (2013).
9. Stephen B. Thacker & Guthrie S. Birkhead, Surveillance, in FIELD EPIDEMIOLOGY 39, 41
(Michael B. Gregg ed., 2008).
10. See, e.g., Donna Behler MacArthur, Emerging Infectious Diseases, 54 NURSING CLINICS
N. AM. 297, 298 (2019) (discussing generally factors related to the spread of emerging infectious
diseases and the difficulties of managing their spread); Vikram P. Krishnasamy et al., Update:
Characteristics of a Nationwide Outbreak of E-Cigarette, or Vaping, Product Use-Associated Lung
Injury–United States, August 2019–January 2020, 69 MORBIDITY & MORTALITY WKLY. REP. 90,
90 (2020) (discussing the mapping of an EVALI outbreak, a lung disease associated with the use
of vaping products); Caitlin M. Rivers & Samuel V. Scarpino, Modelling the Trajectory of Disease
Outbreaks Works, 559 NATURE 477, 477 (2018) (noting the importance of modeling and
surveillance for addressing pandemics).
11. See MacArthur, supra note 10; see also CDC Case Surveillance, supra note 2.
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as how the disease spreads across populations. 12 This Article uses the parallel
term “sociodemographic” to refer to these data as it implicates a larger set of
social, societal, and structural factors that frequently correspond with population
characteristics and contribute to health outcomes. 13 These factors are
characterized in public health practice as social determinants of health. 14
Sociodemographic data help identify populations that experience
disproportionate impacts of disease and may help provide indicators of the
social, environmental, economic, and other conditions in which those
populations live. 15 These data are also critical for examining the environments

12. See ENCYCLOPEDIA OF RESEARCH DESIGN 346 (Neil J. Salkind ed., 2010); see, e.g.,
Jonathan W. Dyal, COVID-19 Among Workers in Meat and Poultry Processing Facilities – 19
States, April 2020, 69 MORBIDITY & MORTALITY WKLY. RPT. 557, 559 tbl.2 (2020); Jazmyn T.
Moore et al., Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic
Groups in Counties Identified as Hotspots During June 5–18, 2020 — 22 States, February–June
2020, 69 MORBIDITY & MORTALITY WKLY. RPT. 1122, 1123 (2020); Hazel Williams-Roberts et
al., Facilitators and Barriers of Sociodemographic Data Collection in Canadian Health Care
Settings: A Multisite Case Study Evaluation, 17 INT’L J. EQUITY HEALTH 186, 187 (2018).
13. While the terms may be used interchangeably, some researchers distinguish between them
to highlight broader contextual factors and corresponding trends, which is the approach being taken
in this Article. See, e.g., Minnesota Health Equity Data Analysis, HEDA Population Step:
Demographic and Socio-Demographic Data for Minnesota Counties, MINN. DEP’T OF HEALTH,
https://www.health.state.mn.us/data/mchs/genstats/heda/demographics.html (last visited Apr. 20,
2021) (characterizing “demographic” data as referring to “population by race and age” and
“sociodemographic” data as referring to “poverty, graduation rate, and owner-occupied housing”);
see also Williams-Roberts et al., supra note 12.
14. See, e.g., Health Equity Considerations and Racial and Ethnic Minority Groups, CTRS.
FOR DISEASE CONTROL & PREVENTION, https://www.cdc.gov/coronavirus/2019-ncov/community
/health-equity/race-ethnicity.html (last updated Apr. 19, 2021) (identifying social determinants of
health as “the conditions in the places where people live, learn, work, play, and worship that affect
a wide range of health risks and outcomes,” and noting that discrimination in “systems” and
“social” inequities placed many members of racial and ethnic minority populations at greater risk
for contracting COVID-19); Populations and Vulnerabilities, CTRS. FOR DISEASE CONTROL &
PREVENTION, https://ephtracking.cdc.gov/showPcMain.action (last updated Oct. 21, 2020)
(“Understanding population characteristics is essential for public health practices such as program
planning, epidemiologic studies, and public health emergency preparedness. Knowing a
population’s characteristics, including their vulnerabilities and resources, can help public health
professionals determine possible effects of health problems or environmental conditions on disease
trends.”); Megan Daugherty Douglas et al., Missed Policy Opportunities to Advance Health Equity
by Recording Demographic Data in Electronic Health Records, 105 AM. J. PUB. HEALTH S380,
S380 (2015) (discussing the importance of collecting not only demographic data but also granular
data in electronic health records to address health disparities); Heather Allen & Rebecca Katz,
Demography and Public Health Emergency Preparedness: Making the Connection, 29 POPULAR
RSCH. POL’Y REV. 527, 530 (2010).
15. See, e.g., Health Equity Considerations and Racial and Ethnic Minority Groups, supra
note 14; Populations and Vulnerabilities, supra note 14; Douglas et al., supra note 14; Allen &
Katz, supra note 14.
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that contribute to disparate health outcomes across populations. 16 Equally
important is identifying populations that not only may experience excess
morbidity and mortality, but also may confront fear, stigma, and discrimination
in their daily lives and as a result of their health status. 17
Disease reporting laws help to facilitate the collection of data that can be
used to explore the impact of disease on populations that experience healthharming societal disadvantages on account of sociodemographic factors like
race, ethnicity, socioeconomic status, occupation or industry, pregnancy status,
and geographic location, among others. 18 Moreover, as public health practice
continues to establish frameworks to advance equity in health outcomes, disease
surveillance can play an important role in building an evidence base about the
association between societal conditions and greater morbidity and mortality in
certain communities. 19 Indeed, as “[p]ublic health work is built on disease or
injury surveillance data . . . the elements collected in data systems are what
shape that foundation.” 20
III. LAWS THAT ADDRESS SOCIODEMOGRAPHIC DATA REPORTING
Sociodemographic data have long been recognized as important dimensions
of disease reporting, but the inadequate collection of these data has posed a
persistent, yet underexamined, challenge. 21 For example, during the period
16. Health Equity Considerations and Racial and Ethnic Minority Groups, supra note 14. See
also Allen & Katz, supra note 14.
17. Sonja S. Hutchins et al., Protecting Vulnerable Populations from Pandemic Influenza in
the United States: A Strategic Imperative, 99 AM. J. PUB. HEALTH S243, S243 (2009). See also
Health Equity Considerations and Racial and Ethnic Minority Groups, supra note 14 (identifying
discrimination on the basis of race or ethnicity as a factor that places some people at increased risk
for COVID-19); JENNIFER S. MIDDLEBROOKS & NATALIE C. AUDAGE, THE EFFECTS OF
CHILDHOOD STRESS ON HEALTH ACROSS THE LIFESPAN 4 (2008) (describing health outcomes
associated with toxic stress, which “results from adverse experiences that may be sustained for a
long period of time. This type of stress can . . . lead to long-term health problems.”).
18. See Hutchins et al., supra note 17, at S246.
19. This goes beyond merely collecting data on incidences of disease among populations and
facilitates the identification of policies, practices, and structural conditions that contribute to disease
spread. Id. at S243–44. See also Sandra Crouse Quinn & Supriya Kumar, Health Inequalities and
Infectious Disease Epidemics: A Challenge for Global Health Security, 12 BIOSECURITY &
BIOTERRORISM 263, 268 (2014) (noting that countries can “use the periods between pandemics to
examine the mechanisms by which unequal levels of disease and mortality may arise”).
20. Hazel D. Dean, A Public Health Approach to Achieving Health Equity, ASS’N OF STATE
& TERRITORIAL HEALTH OFFS.: ASTHO EXPERTS BLOG (Apr. 3, 2017, 2:09 PM),
https://www.astho.org/StatePublicHealth/A-Public-Health-Approach-to-Achieving-Health-Equi
ty/4-3-17/. See also Bruce G. Link & Jo C. Phelan, Editorial: Understanding Sociodemographic
Differences in Health—The Role of Fundamental Social Causes, 86 AM. J. PUB. HEALTH 471, 471–
72 (noting that “societies continue to shape patterns of disease”).
21. James W. Buehler et al., The Reporting of Race and Ethnicity in the National Notifiable
Diseases Surveillance System, 104 PUB. HEALTH REPS. 457, 458–59 (1989) (noting that states only
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between 2006 and 2010, about thirty percent of cases reported to NNDSS lacked
information about race and about fifty-one percent of reported cases lacked
information about ethnicity. 22 In another example, a search of the literature
between 2006 and 2015 indicated that occupation and workplace data were
available for a few specific industries, rather than across labor forces and
workplaces; accordingly, limited research has thus far examined the conditions
that may place workers at increased risk of exposure to infectious diseases. 23
These examples of gaps in data collection raise questions about the extent to
which state disease reporting laws require the reporting of sociodemographic
data and whether such a mandate might help to mitigate reporting gaps. While
the lack of available sociodemographic data cannot be attributed to a single
factor, one reason that jurisdictions do not routinely collect this information
might lie with the lack of legal incentive to do so. As described above, the statelevel mandatory reporting of identified diseases and conditions facilitates the
collection of data necessary to assess the burden of disease and injury within and
across populations. 24 However, gaps in these data may also be due, in part, to
the substantial variations in reporting requirements across jurisdictions. 25 These
variations are significant for two main reasons: first, they can influence the
manner in which a public health response unfolds in the face of a widespread
outbreak or other public health emergency; 26 second, they may contribute to
gaps in the reporting of data necessary to assess impacts of disease on specific
populations. 27 While law cannot accurately be framed as the sole solution to

began reporting in a computer-based network for disease reporting to CDC’s NNDSS in 1985 and
identifying variation in the scope of demographic data reported: e.g., for 1987, while ninety-five
percent of case reports specified age and ninety-nine percent reported gender, only sixty percent
include race-ethnicity). See also Nelson Adekoya et al., Completeness of Reporting of Race and
Ethnicity Data in the Nationally Notifiable Diseases Surveillance System, United States, 2006–
2010, 21 J. PUB. HEALTH HEALTH MGMT. & PRAC. E16, E19 (2015); Dean, supra note 20 (“[M]any
data systems in use have not kept pace with the changing U.S. demographics and need to be
updated.”); Alfonso Rodriguez-Lainz et al., Collection of Data on Race, Ethnicity, Language, and
Nativity by US Public Health Surveillance and Monitoring Systems: Gaps and Opportunities, 133
PUB. HEALTH REPS. 45, 49 (2018).
22. Adekoya et al., supra note 21.
23. Chia-ping Su et al., Case Investigations of Infectious Diseases Occurring in Workplaces,
United States, 2006–2015, 25 EMERGING INFECTIOUS DISEASES 397, 398 (2019). See also
Investigating and Responding to COVID-19 Cases in Non-Healthcare Work Settings:
Considerations for State and Local Health Departments, CTRS. FOR DISEASE CONTROL &
PREVENTION,
https://www.cdc.gov/coronavirus/2019-ncov/php/open-america/non-healthcarework-settings.html (last updated Oct. 21, 2020).
24. Theodore C. Falk, AIDS Public Health Law, 9 J. LEGAL MED. 529, 530 (1988).
25. Danila et al., supra note 6.
26. Id.
27. See U.S. DEP’T OF HEALTH & HUM. SERVS., COVID-19 PANDEMIC RESPONSE,
LABORATORY DATA REPORTING: CARES ACT SECTION 18115 (Jan. 8, 2021); COVID-19 Data
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complex issues related to healthcare capacity and data sharing, law can serve as
a tool for understanding the breadth and scope of reporting requirements that
health departments follow and implement in carrying out disease reporting. 28
As a starting point to understanding gaps in the collection of
sociodemographic data, researchers at CDC’s Public Health Law Program
(PHLP) conducted a legal epidemiological scan of state disease reporting laws
in all fifty states, focusing specifically on requirements to report
sociodemographic information. 29 Each state’s legal code includes a chapter—
Reporting for Non-Lab-Based Testing, U.S. DEP’T OF HEALTH & HUM. SERVS., https://www.hhs
.gov/sites/default/files/non-lab-based-covid19-test-reporting.pdf (last visited June 9, 2021).
28. See National Notifiable Diseases Surveillance System (NNDSS), CTRS. FOR DISEASE
CONTROL & PREVENTION, https://wwwn.cdc.gov/nndss/ (last updated Mar. 13, 2019). Notably, the
passage of the Health Information Technology for Economic and Clinical Health (HITECH) Act
expanded the use of electronic health records for collecting and recording health data and
concomitant demographic data. Over time, observers have noted that while this kind of “federal
legislation can be a powerful stimulus for change, its effectiveness in context depends on its ability
to accommodate private health care markets, as well as diversity in state and local policies.” Marsha
Gold & Catherine McLaughlin, Assessing HITECH Implementation and Lessons: 5 Years Later,
94 MILBANK Q. 654, 679 (2016). Indeed, as variations between state and local laws and policies
governing health data persist long after HITECH implementation, the need for systematic analysis
and tracking of reporting requirements continues. See also Douglas et al., supra note 14, at S380–
81, S387 (discussing the HITECH Act’s imposition of baseline requirements to collect limited
demographic data and emphasizing the need to collect more granular data in electronic health
records to address health disparities).
29. A team of five PHLP researchers conducted a legal scan of disease reporting laws, which
included statutes and regulations, for the fifty U.S. states. Researchers first isolated the entire
disease reporting chapters from each of the fifty states from a legal database, WestlawNext. They
conducted background research to identify patient sociodemographic factors for which data might
be needed in order to assess disease burden across populations. This information was incorporated
into three coding questions to systematically review each state statute and regulation: (1) does the
law require demographic information to be reported; (2) if yes, who is required to report
demographic information (health care provider/facility; laboratory; other; N/A); and (3) if yes, what
demographic information is explicitly required to be reported (Name, Address, Telephone number,
Occupation/employer, Race or ethnicity, Social Security Number, Sex, Age, Date of Birth, Date of
Death, Country of Origin, Citizenship Status, Gender, Sexual Orientation, Pregnancy status,
Insurance status/payor source, Other, N/A). Researchers included what is arguably also
characterizable as personally identifiable information, such as Name, Address, and Telephone
Number, because some researchers have considered how they may have utility in the collection of
sociodemographic data. See, e.g., David L. Word et al., Demographic Aspects of Surnames from
Census 2000, U.S. CENSUS BUREAU, https://www2.census.gov/topics/genealogy/2000surnames
/surnames.pdf (last visited June 9, 2021); Konstantinos Tzioumis, Data Descriptor: Demographic
Aspects of First Names, SCI. DATA (Mar. 6, 2018), https://www.nature.com/articles/sdata201825.
Researchers utilized the Public Health Law Information Portal (PHLIP) to code for the presence or
absence of each legal attribute included in the three coding questions. Quality assurance checks
were conducted by attorney researchers to review each coding decision made for each of the fifty
jurisdictions (five states were coded by all five researchers, and all remaining states were doublecoded by two researchers.). The validated dataset was then used to assess findings related to
mandatory reporting of patient sociodemographic information as part of state disease reporting
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typically located in its health or public health section—consisting of provisions
that set out requirements for the reporting of diseases and conditions. 30
Researchers analyzed these statutes and regulations for the presence or absence
of express requirements to submit sociodemographic information. 31 This study
did not assess agency-level policies on disease reporting, which are typically not
included in state statutes or regulations. Nor did this study examine the
information that health departments request through forms or internet-based
portals that might capture sociodemographic data. These types of policies also
play a role in sociodemographic data collection and may benefit from future
research. 32
IV. FINDINGS
Documented gaps in sociodemographic data collection raised questions
about whether states have laws imposing requirements for the reporting of
sociodemographic data within their disease reporting chapters. 33 For example,
an assessment of disease surveillance laws and their relationship to case
reporting of 2009 H1N1 infections found that although forty-nine jurisdictions
around the country described encountering no problems related to a lack of legal
authority to collect case data and report it to CDC, thirty jurisdictions cited the
reason for not collecting sociodemographic data like race, ethnicity, or obesity
status as “lack of staff resources or unavailability of data from medical
providers.” 34 This important and broad finding still left an open question about
the scope of reporting requirements imposed by state laws.
PHLP’s legal epidemiological scan showed that forty-eight states had
statutory or regulatory provisions in their disease reporting chapters that
expressly required the reporting of sociodemographic data for at least one
laws. See, e.g., Tara Ramanathan et al., Legal Epidemiology: The Science of Law, 45 J.L., MED. &
ETHICS (SPECIAL SUPPLEMENT TO ISSUE 1) 69, 69 (2017) (discussing the study of legal
epidemiology).
30. E.g., ARIZ. ADMIN. CODE § R9-6-204 (2020) (located within the Health Services title of
the state’s Administrative Code, this provision contains the clinical laboratory director reporting
requirements).
31. This coding scheme captured whether a state had a provision requiring demographic data
reporting somewhere within the disease reporting statutes or regulations but did not differentiate a
state that required demographic data reporting for all reportable diseases and conditions from a
state that required such reporting only for a subset of reportable diseases or conditions.
32. See discussion infra Section V.B.
33. These gaps might be even more pronounced in certain communities. For example,
researchers have noted the “excessive absence” of public health data among non-Hispanic
American Indian and Alaska Native (AI/AN) persons, highlighting a need for additional case
investigation and reporting. Sarah M. Hatcher et al., COVID-19 Among American Indian and
Alaska Native Persons - 23 States, January 31-July 3, 2020, 69 MORBIDITY & MORTALITY WKLY.
REP. 1166, 1167 (2020).
34. Danila et al., supra note 6, at 15.
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reportable disease or condition. 35 State laws varied in the situations that trigger
reporting of sociodemographic data, with jurisdictions either requiring this
reporting for any finding of a reportable disease or condition or requiring it only
for the diagnosis of a specific reportable disease or condition, such as HIV or
tuberculosis. 36 Typically, public health departments collect disease reporting
data from those who directly ascertain findings of reportable diseases or
conditions, namely healthcare providers, healthcare facilities, and laboratories.
Indeed, forty-eight states required healthcare providers or facilities and fortyfive states required laboratories to submit sociodemographic data for findings of
reportable diseases or conditions. 37 At the same time, some states also imposed
reporting requirements on additional actors such as school administrators, 38 day
care centers, 39 correctional facilities, 40 “person[s] in charge of a licensed house
35. E.g., ALA. ADMIN. CODE r. 420-4-1-.04(7) (2014). The two states with no explicit
sociodemographic reporting requirements in disease reporting statutes or regulations were Georgia
and Tennessee. E.g., TENN. COMP. R. & REGS. 1200-14-01-.02(1) (2019). One additional state,
Oklahoma, required the reporting of demographic information, but did not enumerate any specific
markers to be reported; researchers characterized this as requiring the reporting of
sociodemographic data. OKLA. ADMIN. CODE § 310:515-1-2 (2020) (“The diseases listed in this
Chapter must be reported, along with patient identifiers, demographics, and contact information to
the Department upon discovery[.]”). See additional discussion, infra page 8. Therefore, researchers
determined that forty-eight states required the reporting of any demographic data, and forty-seven
states expressly required the reporting of at least an individual’s name and address. Also of note,
Wyoming required the reporting of “demographic information” as well as age and gender to its
“Colorectal Cancer Early Detection Program,” 048.0046.18 WYO. CODE R. § 2 (2007), and it
otherwise required physicians to report sociodemographic data for other cases using an “official
State Disease Case Report or equivalent format.” WY RULES AND REGULATIONS 048.0046.1 WYO.
CODE R. § 6(a) (2001). This Case Report, as with Oklahoma, included sociodemographic data.
WYO. DEP’T OF HEALTH, CONFIDENTIAL DISEASE REPORT (2012).
36. E.g., ARIZ. ADMIN. CODE § R9-6-204 (2018) (requiring laboratories to report name,
address, telephone, email, date of birth, and gender for cases of reportable diseases generally, but
adding the reporting of race and ethnicity for reporting of positive HIV cases); CAL. CODE REGS.
tit. 17 § 2504 (2021) (requiring out of state laboratories to report cases of tuberculosis pursuant to
§ 2500(b), which requires the reporting of demographic data pursuant to § 2500(d)); 048.0046.18
WYO. CODE R. § 2 (2007) (requiring health care providers to report demographic information in
conjunction with cases of colon cancer). As researchers set out to determine the extent to which
mandates to report sociodemographic data exist at all, the coding scheme for the instant scan was
not structured to tie each mandate to specific diseases or conditions. Please see the “Limitations”
and “Considerations” sections of this Article for further discussion, infra pp. 15–16.
37. E.g., ALA. ADMIN. CODE r. 420-4-1-.04(1) (2014) (identifying physicians, nurses, medical
examiners, hospital administrators, laboratory directors, among others to report); CAL. CODE REGS.
tit. 17 § 2500(b) (2021) (imposing a “duty” on “every health care provider”); N.H. REV. STAT.
ANN. § 141-C:7(I) (2003) (requiring “any health care provider, clinical laboratory director, the
superintendent or other person in charge of any hospital, or other health care facility,” among
others); S.D. ADMIN. R. 44:20:02:02 (2011); TEX. HEALTH & SAFETY CODE ANN. § 81.042 (2015).
38. E.g., 007.15.2 ARK. CODE R. § III(C) (2019).
39. E.g., CONN. AGENCIES REGS. § 19a-36-A3(a)(3)(A) (1989).
40. E.g., 10-144-258 ME. CODE R. § 2 (A)(5) (2020).
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of prostitution,” 41 or “any other person[s] having knowledge of any disease
which may threaten the public health.” 42
State laws also varied in the scope of sociodemographic information
required. Forty-seven states listed specific data to be reported, and researchers
identified only one state whose laws required sociodemographic reporting for at
least one reportable disease without specifying any data element. 43 Forty-six
states explicitly required the collecting and reporting of patient names and
addresses, 44 but they varied in their requirements to collect information about
race or ethnicity, sex, gender, occupation, or pregnancy status.
PHLP researchers observed that of the forty-seven states with statutes or
regulations that required the reporting of specific elements of sociodemographic
data, thirty-nine required reporting of a patient’s race or ethnicity. 45 Eight of the
forty-seven states imposed no specific mandate within disease reporting laws to
report racial or ethnic information. 46 Reporting requirements related to sex and
gender also varied across these forty-seven jurisdictions. Thirty-five states
expressly required the reporting of sex, sixteen required the reporting of gender,
and eight required both sex and gender to be reported. 47 California, for example,
separately required the reporting of gender identity and sex assigned at birth. 48

41. E.g., NEV. ADMIN. CODE § 441A.815(1) (1992).
42. E.g., MINN. R. 4605.7070 (2005).
43. Compare ALA. ADMIN. CODE r. 420-4-1-.04(7) (2014) (listing specific data to be
reported), with OKLA. ADMIN. CODE § 310:515-1-2 (2019) (omitting any specific data elements to
be reported).
44. E.g., 10-144-258 ME. CODE R. § 2(B) (2020). As discussed supra note 35, the laws
examined for Georgia, Oklahoma, Tennessee, and Wyoming did not specify name and address.
45. E.g., ALA. ADMIN. CODE r. 420-4-1-.04(7) (2014).
46. The eight states that did not impose an explicit mandate within disease reporting laws to
report racial or ethnic information were Hawaii, New York, North Dakota, Oregon, South Carolina,
Vermont, Washington, and Wyoming. E.g., N.D. ADMIN. CODE 33-06-02-01(2) (1996). Of note,
Hawaii’s Access to Medical Records regulation states that “every person, health care provider, and
medical facility shall provide the patient’s . . . race or ethnicity . . . when requested” by the health
department during an epidemiologic investigation and the department has the authority to require
race or ethnicity be reported by health care providers when the department determines that a
dangerous disease outbreak requires monitoring to protect public health. HAW. CODE R. § 11-1564.2(b)–(c) (2009). Researchers did not include this instance as within the scope of a mandatory
disease reporting requirement for purposes of this report due to this ambiguity in language.
47. E.g., 007.15.2 ARK. CODE R. § IV(A)(3) (2019) (requiring the reporting of sex); ARIZ.
ADMIN. CODE § R9-6-204(B) (2020) (requiring the reporting of gender); 6 COLO. CODE REGS. §
1009-1(1) (2019) (requiring the reporting of both sex and gender). Eight states’ laws required only
gender and not sex to be reported, while twenty-seven states required reporting of only sex and not
gender. Compare ARIZ. ADMIN. CODE § R9-6-204(B) (2020) (requiring only the reporting of
gender, not sex), with 007.15.2 ARK. CODE R. § IV(A)(3) (2019) (requiring only the reporting of
sex, not gender).
48. CAL. CODE REGS. tit. 17 § 2505(b) (2021); CAL. CODE REGS. tit. 17, § 2500(d)(1) (2021).
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Forty-six of these forty-seven states specified the reporting of age or date of
birth. 49
Thirteen states required the reporting of pregnancy status for at least one
disease or condition. 50 Conversely, thirty-four of the forty-seven states that
specified at least one sociodemographic marker for reporting did not require the
reporting of pregnancy status. 51 Seventeen of the forty-seven states required the
reporting of occupation, place of work, or industry when providing patient data;
correspondingly, thirty states did not. 52 Uniquely, New Hampshire required
reporting of the patient’s occupation and place of occupation. 53

49. E.g., ALA. ADMIN. CODE r. 420-4-1-.04(7) (2014). In addition to Georgia, Oklahoma, and
Tennessee, South Carolina only explicitly required the reporting of name and address. S.C. CODE
ANN. § 44-29-10(A) (2002).
50. These were: Alaska (ALASKA ADMIN. CODE tit. 7, § 27.005(c) (2018) (“whether that
person is pregnant”)); Arizona (ARIZ. ADMIN. CODE § R9-6-202(C)(1)(j) (2018) (“[i]f known,
whether the individual is pregnant”)); California (CAL. CODE REGS. tit. 17, § 2505(c), (d)(1)
(2021)); Florida (FLA. ADMIN. CODE r. 64D-3.030(3)(a)(8), 3.031(3)(a)(8) (2006)); Iowa (IOWA
CODE ANN. § 139A.3(1)(k) (West 2006); IOWA ADMIN. CODE r 641-1.4(135,139A)(2)(k) (2017));
Kansas (KAN. ADMIN. REGS. § 28-1-2(d)(1)(H) (2017); KAN. STAT. ANN. § 65-6002(b) (2001));
Kentucky (902 KY. ADMIN. REGS. 2:020 (2016)); Louisiana (LA. ADMIN. CODE tit. 51, §§ 105(A),
107(A) (2019)); Minnesota (MINN. R. 4605.7090(L) (2017)); Nebraska (173 NEB. ADMIN. CODE,
§ 1-005.01(D)(7) (2017)); Texas (25 TEX. ADMIN. CODE § 97.3(a)(3)(F) (2017) (for Hepatitis A,
B, C, and E)); Utah (UTAH ADMIN. CODE r. 386-702-7(1)(a)(ix) (2018)); and Virginia (12 VA.
ADMIN. CODE § 5-90-90(A)–(C) (2016)). Some state laws required the reporting of pregnancy
status only for certain diseases. For example, Minnesota required pregnancy status and expected
date of delivery “if the infection can be transmitted during pregnancy or delivery.” MINN. R.
4605.7090(L) (2017).
51. See, e.g., N.H. CODE ADMIN. R. He-P 301.03 (2016).
52. These seventeen states include: Alabama (ALA. CODE § 22-11A-14(b) (2018) (applies to
sexually transmitted diseases)); Arizona (ARIZ. ADMIN. CODE § R9-6-202(C)(1)(l) (2018) (“[i]f
known, the individual’s occupation”)); California (CAL. CODE REGS. tit. 17, § 2500(d)(1) (2021)
(“if known . . . occupation”)); Connecticut (CONN. AGENCIES REGS. §§ 19a-36-A4(a)(1), A11(a)
(1989) (“occupation”)); Illinois (ILL. ADMIN. CODE tit. 77, § 696.170(a)(2)(C) (2012) (reporting of
occupation applies to tuberculosis cases only)); Louisiana (51 LA. ADMIN. CODE tit. 51, § 105(A)
(2019) (“occupation, employer information” required for reports of “occupational
disease/injury”)); Massachusetts (105 MASS. CODE REGS. § 300.180(D) (applies to work-related
diseases and injuries only and requires reporting of employer name, place where occupational
exposure or injury occurred, and individual occupation if known)); Minnesota (MINN. R.
4605.7090(D)(7) (2017) (“place of work”)); Nevada (NEV. ADMIN. CODE §§ 441A.230(2)(d),
441A.243(2)(d), 441A.815(3)(d) (2011, 2011, 1992) (“occupation, employer . . . if available”));
New Hampshire (N.H. CODE ADMIN. R. ANN. He-P 301.03(b)(1) (2016) (“occupation and place of
occupation”)); New Mexico (N.M. CODE R. § 7.4.3.13A(2) (2016) (“occupation”)); New York
(N.Y. COMP. CODES R. & REGS. tit. 10, § 2.41(a) (1994) (applies to typhoid)); North Dakota (N.D.
ADMIN. CODE 33-06-02-01(2) (1996)); Ohio (OHIO ADMIN. CODE 3701-3-02.1(A)(1) (2014));
South Dakota (S.D. ADMIN. R. 44:20:02:05(2) (2011)); Texas (25 TEX. ADMIN. CODE §
97.3(a)(3)(I) (2017) (for Hansen’s disease)); and Virginia (12 VA. ADMIN. CODE § 5-90-180
(2004)).
53. N.H. CODE ADMIN. R. ANN. He-P 301.03(b)(1) (2016).
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No states required reporting of citizenship status in their disease reporting
laws, and three states required reporting on country of origin. 54 Only California
required the reporting of sexual orientation. 55
V. DISCUSSION
As reflected in the findings discussed above, this scan of legal provisions in
state disease reporting chapters suggests that states are attuned to the importance
of capturing sociodemographic data, particularly with respect to individual
patient location, sex, age (and by proxy, date of birth), and race or ethnicity. At
the same time, these reporting requirements are not universally mandated across
all jurisdictions and across all conditions, which may result in wide variation
across the states’ sociodemographic reporting outcomes. These findings,
therefore, raise a question about the state of disease surveillance laws: would
further promulgation of sociodemographic data reporting requirements help
mitigate reporting gaps shown in other studies, and if so, how?
Correspondingly, this scan suggests that there are areas of
sociodemographic data reporting that could receive more attention in law. For
example, as previously highlighted, thirty-four states did not require the
reporting of pregnancy status, and even among states that did, some only
required it “if known,” a designation that is prone to ambiguity. 56 Researchers
have emphasized “the unique vulnerabilities of pregnant women and infants to
emerging health threats,” as well as the importance of surveillance systems for
understanding the impact of disease or emergencies to inform both clinical
decision-making and approaches to prevention. 57 Valuable information for
examining and tracking health outcomes among pregnant women can be lost
where jurisdictions do not prioritize the collection of these disease reporting
data. 58
54. These were Illinois (ILL. ADMIN. CODE tit 77, § 696.170(a)(2)(C) (2012)); Michigan
(MICH. ADMIN. CODE r. 325.173(13)); and Texas (25 TEX. ADMIN. CODE § 97.3(a)(3)(D) (2017)).
55. CAL. CODE REGS. tit. 17, § 2500(d)(1) (2021).
56. It suggests not only reliance upon the individual patient’s knowledge and disclosure of
pregnancy status, but also reliance upon the reporter to make the inquiry and document such
information.
57. Meghan T. Frey et al., Surveillance for Emerging Threats to Pregnant Women and Infants,
28 J. WOMEN’S HEALTH 1031, 1031 (2019).
58. E.g., Martha Anker, Pregnancy and Emerging Diseases, 13 EMERGING INFECTIOUS
DISEASES 518, 518 (2007). See also, e.g., Deshayne B. Fell et al., Maternal Influenza and Birth
Outcomes: Systematic Review of Comparative Studies, 124 BJOG 48, 56 (2017); Sascha Ellington
et al., Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2
Infection by Pregnancy Status — United States, January 22–June 7, 2020, 69 MORBIDITY &
MORTALITY WKLY. REP. 769, 772 (2020) (noting that data on pregnancy status were available for
91,412 women among a sample size of 326,335 women of reproductive age who were positive for
COVID-19 and discussing CDC’s creation of a pregnancy surveillance system to fill data-reporting
gaps).
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As noted previously, a majority of states (thirty of forty-seven) that required
the reporting of specific sociodemographic markers did not require the reporting
of employment or occupation data, despite the singular risks that workplace
settings can pose to disease spread. 59 Part of this difficulty might arise because
diseases associated with the workplace or occupational diseases are typically
reported, if at all, via workers’ compensation or other, seemingly disparate,
mechanisms. 60 Some diseases, including influenza and other types of
communicable respiratory infections, may not ordinarily be characterized as
occupational diseases, but they nevertheless may be connected to specific
workplaces and settings. 61 Accordingly, questions abound about whether state
disease reporting systems can be enhanced with a more robust collection of these
data, and how law may serve as a tool to help bring this to fruition.
A.

Limitations of the Legal Epidemiological Scan

There are several limitations to these findings. Perhaps most importantly,
the law as written on the books does not always capture the policies and practices
as they are developed and implemented by public health and health care
practitioners. For example, Georgia’s law did not include an express provision
in statutes or regulations that required the reporting of sociodemographic data,
but its Notifiable Disease/Condition Report Form, which providers and
laboratories send to the health department, carves out space for
sociodemographic data, such as race, ethnicity, age, sex, and other factors. 62 The
existence of these reporting mechanisms in most states, either through law or
public health practice, makes the underreporting of sociodemographic data even
more surprising. While the research conducted for the purposes of this Article
offers an instructive window into the states’ legislative and executive branch
59. See, e.g., Eugene Freund et al., Mandatory Reporting of Occupational Diseases by
Clinicians, MMWR (June 22, 1990), https://www.cdc.gov/mmwr/preview/mmwrhtml/000016
66.htm; NAT’L INST. FOR OCCUPATIONAL SAFETY & HEALTH, NIOSH 2008-128, NIOSH ALERT,
PROTECTING POULTRY WORKERS FROM AVIAN INFLUENZA 7 (BIRD FLU) (2008); Marissa G.
Baker et al., Estimating the Burden of United States Workers Exposed to Infection or Disease: A
Key Factor in Containing Risk of COVID-19 Infection, PLOS ONE, Apr. 28, 2020, at 1, 6.
60. See, e.g., Su et al., supra note 23 (noting that workplace diseases are identified via workers,
employers, workplace health and safety offices, public health departments that receive case reports
from clinicians and labs, and the CDC); Kathleen Kreiss & Kristin J. Cummings, Field
Epidemiology Manual: Occupational Disease and Injury, CTRS. FOR DISEASE CONTROL &
PREVENTION, https://www.cdc.gov/eis/field-epi-manual/chapters/Occupational.html (last updated
Dec. 13, 2018).
61. Disease and Injury: Infectious Diseases, NAT’L INST. FOR OCCUPATIONAL SAFETY &
HEALTH,
https://www.cdc.gov/niosh/docs/96-115/diseas.html#Infectious%20Diseases
(last
updated June 6, 2014).
62. Notifiable Disease/Condition Report Form, GA. DEP’T OF PUB. HEALTH, https://dph
.georgia.gov/sites/dph.georgia.gov/files/ADES_DPH%20_Reporting_Poster_Form.pdf (last
visited June 15, 2021).
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efforts to collect sociodemographic data, it does not provide a comprehensive
picture of what departments of public health, or individuals reporting disease,
do in practice.
Additionally, while this legal epidemiological scan coded for the presence
or absence of an express requirement to report sociodemographic data, a state
may only require sociodemographic data to be reported for certain conditions
and not for others. For example, Michigan law required practitioners to report a
patient’s sex when diagnosing cases of HIV; 63 accordingly, this study design
would characterize Michigan as requiring the reporting of sex, even if it is not
required with other diagnoses. Sociodemographic information may also be
reported to health department registries, vital records, and other databases—data
that can be linked and analyzed to conduct epidemiological analyses—that are
outside the scope of disease reporting statutes and regulations reviewed in this
scan. Lastly, this study is based on publicly available statutes and regulations as
identified by researchers using the WestlawNext legal database. While coding
results underwent multiple verification steps for quality assurance, results are
subject to the availability of laws and their appropriate inclusion within this
dataset. Because this study is intended to serve as a scan of the legal landscape
surrounding disease reporting laws, and to shed light on the role of law in
creating more comprehensive and informative datasets related to
sociodemographic data and burdens of disease, the results of this study should
not be taken as legal advice or descriptive of a duty to report.
B.

Considerations for Future Research

The researchers view this scan as a starting point in analyzing the factors
contributing to existing gaps in sociodemographic data in the context of disease
reporting. Future research might consider several additional factors that are not
addressed here. For example, research might utilize a methodology that
incorporates a systematic examination of state public health department disease
reporting policies, forms, and electronic interfaces used by healthcare providers
and laboratories for a more comprehensive picture of disease reporting practices.
Such a systematic examination might also expand the universe of potential
demographic markers that state laws might seek to capture in disease reporting,
such as disability status, potential underlying co-morbidities, or socioeconomic
status. It might also stratify demographic markers in relation to specific
diseases—in order to precisely capture those states that impose different
sociodemographic reporting requirements for different diseases or conditions.
Furthermore, it is important to consider the difficulties of capturing and
classifying this type of data in health practice, which may deter health
departments from enforcing disease reporting requirements. Studies have
documented that health departments prefer to collaborate with, rather than
63. MICH. COMP. LAWS ANN. § 333.5114(1)(c) (West 2019).
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penalize, the providers and facilities they work with in order to promote public
health goals. 64 The fact that the law does not account for the reality that health
practitioners face may pose a challenge that public health must solve through
technology, policy, and further collaboration. As such, a subsequent study might
also include a qualitative component, relying on interviews or surveys of
healthcare providers, laboratories, and others tasked with submitting disease
reporting information for their perspectives on barriers to reporting
sociodemographic data to public health departments. Some identified barriers
have included limited or flawed technology, lack of time, or patients opting out
of disclosing this information—challenges that CDC’s Data Modernization
Initiative seeks to mitigate. 65 Future research might also include an examination
of reporting requirements in light of the specific mechanisms used by reporters
to submit this information to public health departments.
VI. CONCLUSION
Disease reporting laws serve a vital role in facilitating the creation of
comprehensive, illustrative datasets that can be used to monitor, respond to, and
prevent future disease and injury. State disease reporting systems contribute to
the utility and reliability of NNDSS and similar surveillance systems, which can
be employed to better understand, and ultimately correct, disproportionate
burdens of disease and injury across populations. A robust collection of
sociodemographic information can inform public health professionals and
policymakers about how best to target interventions and resources, as well as
monitor progress and efficacy of these interventions over time.
Sociodemographic information in disease data can identify those populations
that face substantial morbidity and mortality risk and that may encounter the
most challenging structural and institutional barriers to avoiding or overcoming
that risk.

64. See, e.g., Patricia Stone et al., Impact of Laws Aimed at Healthcare-Associated Infection
Reduction: A Qualitative Study, 24 BMJ QUALITY & SAFETY 637, 639–40 (2015); HealthcareAssociate Infections, Improving Your Access to Electronic Health Records During Outbreaks of
Healthcare-Associated Infections, ASS’N OF STATE & TERRITORIAL HEALTH OFFS.,
https://www.astho.org/Toolkit/Improving-Access-to-EHRs-During-Outbreaks/ (last visited June
15, 2021).
65. Brian E. Dixon et al., Completeness and Timeliness of Notifiable Disease Reporting: A
Comparison of Laboratory and Provider Reports Submitted to a Large County Health Department,
BMC MED. INFORMATICS & DECISION MAKING, June 23, 2017, at 1, 7 (discussing study of case
reports submitted to a large local health department and finding “provider reporting rates, as well
as case report completeness and timeliness, have room for improvement,” and discussing various
administrative and process barriers to complete and timely case reporting); Public Health
Surveillance and Data: CDC Data Modernization Initiative, CTRS. FOR DISEASE CONTROL &
PREVENTION, https://www.cdc.gov/surveillance/surveillance-data-strategies/data-IT-transforma
tion.html (last updated Dec. 9, 2020).
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As the world faces new public health threats and emerging infectious
diseases with the capacity to spread quickly, the need for early warning systems
and rapid public health response becomes even more imperative. 66 Disease
surveillance systems equipped with sociodemographic data can help address the
factors that lead to disproportionate health outcomes. To successfully address
these inequities, public health must develop tools and an evidence base that
accurately depict the myriad ways that sociodemographic factors affect one’s
health.

66. See Peter Nsubuga et al., Public Health Surveillance: A Tool for Targeting and Monitoring
Interventions, in DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES 997, 998–99 (D.T.
Jamison et al. eds., 2d ed. 2006), https://openknowledge.worldbank.org/bitstream/handle/10986
/7242/414600PAPER0Di101Official0Use0Only1.pdf?sequence=1.

